Expert Review of Precision Medicine and Drug Development

Published by Taylor & Francis Group

United Kingdom · Cancer Genomics and Diagnostics

Journal at a glance

ISSN

23808993

Publisher

Taylor & Francis Group

Country

United Kingdom

Language

en

Also known as: Expert Rev Precis Med Drug Dev (Abbreviation), Expert review (Alternate title)

Indexing

• Scopus: Indexed

Metrics

Subjects

• Cancer Genomics and Diagnostics
• Cancer Immunotherapy and Biomarkers
• Lung Cancer Treatments and Mutations
• Pharmacogenetics and Drug Metabolism
• Colorectal Cancer Treatments and Studies
• CAR-T cell therapy research
• Renal cell carcinoma treatment

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Advances in functional radionuclide imaging and therapy for individualized management of patients: the growing importance of Nuclear Theranostics in Precision Oncology Practice (2025)
• Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations (2025)
• Immunotherapy for precision medicine in colorectal cancer (2025)
• Challenges and opportunities for precision medicine in developing nations (2025)
• Drug discovery in the context of precision medicine and artificial intelligence (2024)

Similar journals

• Oncologist — United Kingdom · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total, Same country
• Cancer Discovery — United States · — · Same subject: CAR-T cell therapy research, Same subject: Cancer Genomics and Diagnostics, 4 shared subjects in total
• American Society of Clinical Oncology Educational Book — United States · — · Same subject: CAR-T cell therapy research, Same subject: Cancer Genomics and Diagnostics, 4 shared subjects in total
• Molecular Diagnosis and Therapy — Switzerland · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Colorectal Cancer Treatments and Studies, 4 shared subjects in total
• Lung Cancer: Targets and Therapy — New Zealand · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total
• Forum of Clinical Oncology — Greece · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total

Sources: OpenAlex, NLM Catalog, Crossref, Scopus · Last verified 2026-09-05

Journal homepage